Icu Medical Stock Performance
| ICUI Stock | USD 167.81 0.65 0.39% |
ICU Medical has a performance score of 2 on a scale of 0 to 100. The firm retains a Market Volatility (i.e., Beta) of 1.15, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, ICU Medical will likely underperform. ICU Medical currently retains a risk of 1.53%. Please check out ICU Medical potential upside, as well as the relationship between the kurtosis and day typical price , to decide if ICU Medical will be following its current trending patterns.
Risk-Adjusted Performance
2 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in ICU Medical are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong basic indicators, ICU Medical is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders. ...more
Actual Historical Performance (%)
One Day Return 2.09 | Five Day Return 1.76 | Year To Date Return 69.3 | Ten Year Return 105.64 | All Time Return 3.6 K |
Last Split Factor 3:2 | Last Split Date 2002-03-18 |
1 | Disposition of 2502 shares by Woolson Daniel of ICU Medical at 163.2175 subject to Rule 16b-3 | 08/30/2024 |
2 | ICU Medical, Inc. Hits Fresh High Is There Still Room to Run | 09/17/2024 |
3 | Helene spurs IV fluid shortage. Milton could make it worse | 10/09/2024 |
4 | Disposition of 12000 shares by Vivek Jain of ICU Medical at 88.76 subject to Rule 16b-3 | 11/01/2024 |
5 | Verano Holdings Corp. Reports Q3 Loss, Lags Revenue Estimates | 11/07/2024 |
6 | Wellington Management Group LLP Adjusts Stake in ICU Medical Inc | 11/08/2024 |
7 | ICU Medical earnings beat by 0.34, revenue topped estimates | 11/12/2024 |
8 | ICU Medical Inc Q3 2024 Earnings Call Highlights Strong Revenue Growth and Strategic ... | 11/13/2024 |
9 | ICU Medical Inc Trading Down 2.35 percent on Nov 14 | 11/14/2024 |
10 | ICU Medical, Inc. Just Reported And Analysts Have Been Lifting Their Price Targets | 11/15/2024 |
11 | ICU Medical Future 3-5Y EPS without NRI Growth Ra - GuruFocus.com | 11/22/2024 |
| Begin Period Cash Flow | 208.8 M |
ICU |
ICU Medical Relative Risk vs. Return Landscape
If you would invest 16,391 in ICU Medical on August 27, 2024 and sell it today you would earn a total of 390.00 from holding ICU Medical or generate 2.38% return on investment over 90 days. ICU Medical is currently generating 0.0482% in daily expected returns and assumes 1.5285% risk (volatility on return distribution) over the 90 days horizon. In different words, 13% of stocks are less volatile than ICU, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
ICU Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ICU Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ICU Medical, and traders can use it to determine the average amount a ICU Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0315
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ICUI |
Estimated Market Risk
| 1.53 actual daily | 13 87% of assets are more volatile |
Expected Return
| 0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average ICU Medical is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ICU Medical by adding it to a well-diversified portfolio.
ICU Medical Fundamentals Growth
ICU Stock prices reflect investors' perceptions of the future prospects and financial health of ICU Medical, and ICU Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ICU Stock performance.
| Return On Equity | -0.0535 | ||||
| Return On Asset | 0.0066 | ||||
| Profit Margin | (0.05) % | ||||
| Operating Margin | 0.04 % | ||||
| Current Valuation | 5.47 B | ||||
| Shares Outstanding | 24.48 M | ||||
| Price To Earning | 38.71 X | ||||
| Price To Book | 2.01 X | ||||
| Price To Sales | 1.76 X | ||||
| Revenue | 2.26 B | ||||
| Gross Profit | 697.76 M | ||||
| EBITDA | 307.69 M | ||||
| Net Income | (29.66 M) | ||||
| Cash And Equivalents | 285.59 M | ||||
| Cash Per Share | 11.95 X | ||||
| Total Debt | 1.7 B | ||||
| Debt To Equity | 0.84 % | ||||
| Current Ratio | 2.45 X | ||||
| Book Value Per Share | 83.76 X | ||||
| Cash Flow From Operations | 166.2 M | ||||
| Earnings Per Share | (4.57) X | ||||
| Market Capitalization | 4.12 B | ||||
| Total Asset | 4.38 B | ||||
| Retained Earnings | 807.85 M | ||||
| Working Capital | 739.43 M | ||||
| Current Asset | 505.01 M | ||||
| Current Liabilities | 42.62 M | ||||
About ICU Medical Performance
By evaluating ICU Medical's fundamental ratios, stakeholders can gain valuable insights into ICU Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ICU Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ICU Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 170.42 | 178.94 | |
| Return On Tangible Assets | (0.01) | (0.01) | |
| Return On Capital Employed | 0.01 | 0.01 | |
| Return On Assets | (0.01) | (0.01) | |
| Return On Equity | (0.01) | (0.01) |
Things to note about ICU Medical performance evaluation
Checking the ongoing alerts about ICU Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ICU Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the previous year's revenue of 2.26 B. Net Loss for the year was (29.66 M) with profit before overhead, payroll, taxes, and interest of 697.76 M. | |
| Over 92.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: ICU Medical Future 3-5Y EPS without NRI Growth Ra - GuruFocus.com |
- Analyzing ICU Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ICU Medical's stock is overvalued or undervalued compared to its peers.
- Examining ICU Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ICU Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ICU Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ICU Medical's stock. These opinions can provide insight into ICU Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for ICU Stock analysis
When running ICU Medical's price analysis, check to measure ICU Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICU Medical is operating at the current time. Most of ICU Medical's value examination focuses on studying past and present price action to predict the probability of ICU Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICU Medical's price. Additionally, you may evaluate how the addition of ICU Medical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |